BACKGROUND AIMS: Microvesicles (MV) shed from the plasma membrane of eukaryotic cells, including human embryonic stem cells (hESC), contain proteins, lipids and RNA and serve as mediators of cell-to-cell communication. However, they may also contain immunogenic membrane domains and infectious particles acquired from xenogenic components of the culture milieu. Therefore, MV represent a potential risk for clinical application of cell therapy. METHODS: We tested the ability of hESC and their most commonly used feeder cells, mouse embryonic fibroblasts (MEF), to produce MV. We found that hESC are potent producers of MV, whereas mitotically inactivated MEF do not produce any detectable MV. We therefore employed a combined proteomic approach to identify the molecules that constitute the major components of MV from hESC maintained in a standard culture setting with xenogenic feeder cells. RESULTS: In purified MV fractions, we identified a total of 22 proteins, including five unique protein species that are known to be highly expressed in invasive cancers and participate in cellular activation, metastasis and inhibition of apoptosis. Moreover, we found that hESC-derived MV contained the immunogenic agents apolipoprotein and transferrin, a source of Neu5Gc, as well as mouse retroviral Gag protein. CONCLUSIONS: These findings indicate that MV represent a mechanism by which hESC communicate; however, they also serve as potential carriers of immunogenic and pathogenic compounds acquired from environment. Our results highlight a potential danger regarding the use of hESC that have previously been exposed to animal proteins and cells.

Department of Biology Faculty of Medicine Masaryk University Brno Czech Republic

000      

04187naa 2200673 a 4500

001      

bmc11023064

003      

CZ-PrNML

005      

20121122112457.0

008      

110801s2009 xxk e Eng||

009      

AR

040    __

$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxk

100    1_

$a Kubíková, Iva. $7 _AN067869

245    10

$a Proteomic profiling of human embryonic stem cell-derived microvesicles reveals a risk of transfer of proteins of bovine and mouse origin / $c I. Kubíková, H. Konečná, O. Šedo, Z. Zdráhal, P. Řehulka, H. Hříbková, H. Řehulková, A. Hampl, J. Chmelík, P. Dvořák

314    __

$a Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

520    9_

$a BACKGROUND AIMS: Microvesicles (MV) shed from the plasma membrane of eukaryotic cells, including human embryonic stem cells (hESC), contain proteins, lipids and RNA and serve as mediators of cell-to-cell communication. However, they may also contain immunogenic membrane domains and infectious particles acquired from xenogenic components of the culture milieu. Therefore, MV represent a potential risk for clinical application of cell therapy. METHODS: We tested the ability of hESC and their most commonly used feeder cells, mouse embryonic fibroblasts (MEF), to produce MV. We found that hESC are potent producers of MV, whereas mitotically inactivated MEF do not produce any detectable MV. We therefore employed a combined proteomic approach to identify the molecules that constitute the major components of MV from hESC maintained in a standard culture setting with xenogenic feeder cells. RESULTS: In purified MV fractions, we identified a total of 22 proteins, including five unique protein species that are known to be highly expressed in invasive cancers and participate in cellular activation, metastasis and inhibition of apoptosis. Moreover, we found that hESC-derived MV contained the immunogenic agents apolipoprotein and transferrin, a source of Neu5Gc, as well as mouse retroviral Gag protein. CONCLUSIONS: These findings indicate that MV represent a mechanism by which hESC communicate; however, they also serve as potential carriers of immunogenic and pathogenic compounds acquired from environment. Our results highlight a potential danger regarding the use of hESC that have previously been exposed to animal proteins and cells.

590    __

$a bohemika - dle Pubmed

650    _2

$a zvířata $7 D000818

650    _2

$a antigeny heterofilní $x imunologie $7 D015478

650    _2

$a antigeny nádorové $x imunologie $x metabolismus $7 D000951

650    _2

$a apolipoproteiny $x imunologie $x metabolismus $7 D001053

650    _2

$a proteiny regulující apoptózu $x imunologie $x metabolismus $7 D051017

650    _2

$a skot $7 D002417

650    _2

$a buněčné linie $7 D002460

650    _2

$a mikropartikule $x imunologie $x metabolismus $7 D055252

650    _2

$a kokultivační techniky $7 D018920

650    _2

$a embryonální kmenové buňky $x cytologie $x imunologie $x metabolismus $7 D053595

650    _2

$a fibroblasty $x cytologie $x imunologie $x metabolismus $7 D005347

650    _2

$a genové produkty gag $x imunologie $x metabolismus $7 D015683

650    _2

$a lidé $7 D006801

650    _2

$a myši $7 D051379

650    _2

$a elektronová mikroskopie $7 D008854

650    _2

$a proteomika $7 D040901

650    _2

$a riskování $7 D012309

650    _2

$a tandemová hmotnostní spektrometrie $7 D053719

650    _2

$a tkáňová terapie - dějiny $x škodlivé účinky $7 D014023

650    _2

$a transferin $x imunologie $x metabolismus $7 D014168

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Konečná, Hana, $d 1957- $7 xx0127943

700    1_

$a Šedo, Ondrej, $d 1979- $7 xx0122934

700    1_

$a Zdráhal, Zbyněk $7 xx0074482

700    1_

$a Řehulka, Pavel, $d 1975- $7 xx0034914

700    1#

$a Hříbková, Hana. $7 mzk2006356131

700    1#

$a Řehulková, Helena. $7 xx0204964

700    1_

$a Hampl, Aleš, $d 1962- $7 ola2002153626

700    1#

$a Chmelík, Josef. $7 _BN001654

700    1_

$a Dvořák, Petr, $d 1956- $7 ola2002153627

773    0_

$t Cytotherapy $w MED00010464 $g Roč. 11, č. 3 (2009), s. 330-340 $x 1465-3249

910    __

$a ABA008 $b x $y 2

990    __

$a 20110802111516 $b ABA008

991    __

$a 20121122112519 $b ABA008

999    __

$a ok $b bmc $g 881905 $s 732994

BAS    __

$a 3

BMC    __

$a 2009 $b 11 $c 3 $d 330-340 $m Cytotherapy $n Cytotherapy $i 1465-3249 $x MED00010464

LZP    __

$a 2011-4B09/jvme